CFA
AGN

Camarda Financial Advisors’s Allergan plc AGN Stock Holding History

Camarda Financial Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-15
Closed -$3K – 267
2016
Q4 		$3K Buy
+15
New +$3.11K ﹤0.01% 211
2015
Q2 		– Sell
-91
Closed -$27K – 283
2015
Q1 		$27K Sell
91
-3,506
-97% -$1,000K 0.02% 161
2014
Q4 		$926K Buy
3,597
+1,160
+48% +$290K 0.59% 46
2014
Q3 		$588K Sell
2,437
-57
-2% -$12.8K 0.41% 45
2014
Q2 		$556K Sell
2,494
-768
-24% -$159K 0.38% 47
2014
Q1 		$671K Sell
3,262
-622
-16% -$123K 0.51% 44
2013
Q4 		$653K Buy
+3,884
New +$607K 0.53% 47
2013
Q3 		– Sell
-87
Closed -$11K – 269
2013
Q2 		$11K Buy
+87
New +$9.85K 0.01% 159

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Camarda Financial Advisors's AGN Position: Q1 2017 in Review

Camarda Financial Advisors sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 15 shares — an estimated $3K sold.

Camarda Financial Advisors first reported a position in AGN in Q2 2013 and held it in 8 quarters. The position peaked at $926K in Q4 2014. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Camarda Financial Advisors reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Camarda Financial Advisors sold 15 Allergan plc shares in Q1 2017, an estimated $3K.
  • Camarda Financial Advisors first reported a position in Allergan plc in Q2 2013 and held it in 8 quarters.
  • Camarda Financial Advisors's Allergan plc position peaked at $926K in Q4 2014.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Camarda Financial Advisors's 13F filing for Q1 2017, filed 5 May 2017.